Skip to search formSkip to main contentSkip to account menu

Safety Pharmacology

Known as: SP 
A branch of pharmacology that investigates the potential undesirable pharmacodynamic effects of a substance on physiological functions in relation to… 
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SEND Study Category TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
13th Annual Meeting of the Safety Pharmacology Society: focus on novel technologies and safety pharmacology frontiers
Introduction: The 13th Annual Meeting of the Safety Pharmacology (SP) Society discussed novel therapeutic areas, recent… 
Review
2013
Review
2013
A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions.
Review
2012
Review
2012
A review of the western Pacific species of the crangonid genus Metacrangon Zarenkov, 1965 (Decapoda: Caridea), with descriptions of seven new species
A review of species of the crangonid genus Metacrangon Zarenkov, 1965 (Decapoda: Caridea) from the Northwest andtropical… 
Review
2011
Review
2011
10th annual meeting of the Safety Pharmacology Society: an overview
The 10th annual meeting of the Safety Pharmacology (SP) Society covered numerous topics of educational and practical research… 
2010
2010
Cardiovascular system assessment best practices: a Safety Pharmacology Society meeting
A group of selected Safety Pharmacology (SP) experts (∼ 50) were convened at the Cambridge Amgen Research Center for a brain… 
2008
2008
Safety Pharmacology Society: 7th Annual Meeting
Sir James Black, the 1988 recipient of the Nobel Prize for the invention of propranolol and cimetidine, opened the 2007 Safety… 
2007
2007
Safety Pharmacology Society: 6th Annual Meeting
The Safety Pharmacology (SP) Society annual meeting discussed organ and physiological system safety issues encountered during the… 
Review
2005
Review
2005
Current management of spontaneous pneumothorax.
Spontaneous pneumothorax is divided into primary, when there is no underlying lung disease, and secondary, mainly caused by… 
Review
2002
Review
2002
The application of in vitro methods to safety pharmacology
The ICH S7A guideline defines safety pharmacology (SP) studies as those that investigate `the potential undesirable… 
1982
1982
Synthesis and biological activities of photoaffinity labeling analogues of substance P.
Substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-MetNH2, SP) is an undecapeptide with important properties as a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)